With significant upside potential, Liquidia Corporation (NASDAQ:LQDA) secures a spot on our list of the best small-cap ...
ARS Pharmaceuticals stock has seen its consensus analyst price target decline slightly, dropping from $31.00 to $30.00 per share. This modest adjustment reflects a balance between optimism regarding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback